#OrigiGator Genascence Corporation, a clinical-stage #biotech company, announced the Phase 1 #clinicaltrial data for its osteoarthritis treatment at the European Society of Gene and Cell Therapy 30th Annual Congress. 🧬 They were able to demonstrate that the drug met the primary safety endpoint and was well-tolerated in all study subjects. They also noted encouraging symptomatic improvements! 📈 This is the first step for bringing the tech, licensed from University of Florida College of Medicine's Dr. Steven Ghivizzani, to market. 💉 Learn more, here. ▶️ https://lnkd.in/erdyD-_U
